Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers. Factors such as rising prevalence of different forms of cancer, technological advancements in the field of ablation, rising awareness regarding the benefits offered by ablation procedures over conventional surgical procedures and rising number of hospitals, surgical and ablation centers are driving the growth of tumor ablation market globally.
The report titled “Tumor Ablation Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall tumor ablation market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on technology radiofrequency ablation, microwave ablation, cryoablation and other technologies, treatment surgical ablation, laparoscopic ablation and percutaneous ablation, application liver cancer, lung cancer, kidney cancer, bone metastasis and other applications and different geographical regions. Geographically, the global tumor ablation market is studied for the following regional markets:
Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global tumor ablation market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global tumor ablation market. This report concludes with company profiles section that highlights major information about the key players engaged in global tumor ablation market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report. Thus, the research study provides a holistic view of the global tumor ablation market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Tumor Ablation Market Snapshot
2.2 Global Tumor Ablation Market, by Technology, 2016 (US$ Bn)
2.3 Global Tumor Ablation Market, by Treatment, 2016 (US$ Bn)
2.4 Global Tumor Ablation Market, by Application, 2016 (US$ Bn)
2.5 Global Tumor Ablation Market Share, by Geography, 2016 (Value %)
Chapter 3 Tumor Ablation Market Analysis
3.1 Global Tumor Ablation Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Increase in demand for minimally invasive cancer procedures
3.2.1.2 Rising prevalence of cancer
3.2.2 Challenges
3.2.2.1 Stringent Regulatory Guidelines
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Tumor Ablation Market
Chapter 4 Global Tumor Ablation Market, by Technology
4.1 Overview
4.2 Radiofrequency ablation
4.3 Microwave ablation
4.4 Cryoablation
4.5 Other technologies
Chapter 5 Global Tumor Ablation Market, by Treatment
5.1 Overview
5.2 Surgical ablation
5.3 Laparoscopic ablation
5.4 Percutaneous ablation
Chapter 6 Global Tumor Ablation Market, by Application
6.1 Overview
6.2 Liver cancer
6.3 Lung Cancer
6.4 Kidney Cancer
6.5 Bone metastasis
6.6 Other Application
Chapter 7 Global Tumor Ablation Market, By Geography
7.1 Preface
7.2 North America (U.S. & Canada)
7.3 Europe (U.K., Germany & Rest of Europe)
7.4 Asia Pacific (China, Japan and Rest of APAC)
7.5 Latin America
7.6 Middle East and Africa
Chapter 8 Company Profiles
8.1 Angiodynamics, Inc.
8.2 Boston Scientific Corp.
8.3 BVM Medical Limited
8.4 EDAP TMS S.A.
8.5 Galil Medical, Inc.
8.6 Healthtronics, Inc.
8.7 INTIO Inc.
8.8 Medtronic, Plc.
8.9 Mermaid Medical, Inc.
8.10 Mesonix, Inc.
8.11 Neuwave Medical, Inc.
8.12 Sonacare Medical, LLC
List Of Table :
TABLE 1 Market Positioning of Key Players in Global Tumor Ablation Market
TABLE 2 Global Tumor Ablation Market, by Technology, 2015 – 2025 (US$ Bn)
TABLE 3 Global Tumor Ablation Market, by Treatment, 2015 – 2025 (US$ Bn)
TABLE 4 Global Tumor Ablation Market, by Application, 2015 – 2025 (US$ Bn)
TABLE 5 Global Tumor Ablation Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 6 North America Tumor Ablation Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 7 Europe Tumor Ablation Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 8 Asia Pacific Tumor Ablation Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 9 Angiodynamics, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 10 Boston Scientific Corp.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 11 BVM Medical Limited: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 12 EDAP TMS S.A.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 13 Galil Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 14 Healthtronics, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 15 INTIO Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Medtronic, Plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 17 Mermaid Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 18 Mesonix, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 19 Neuwave Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 20 Sonacare Medical, LLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
List Of Figures :
FIG. 1 Tumor Ablation Market: Research Methodology
FIG. 2 Global Tumor Ablation Market, by Technology, 2016 (US$ Bn)
FIG. 3 Global Tumor Ablation Market, by Treatment, 2016 (US$ Bn)
FIG. 4 Global Tumor Ablation Market, by Application, 2016 (US$ Bn)
FIG. 5 Global Tumor Ablation Market Share, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition: Global Tumor Ablation Market, by Geography, 2016
FIG. 7 Global Radiofrequency ablation Market for Tumor Ablation, 2015 – 2025 (US$ Bn)
FIG. 8 Global Microwave ablation Market for Tumor Ablation, 2015 – 2025 (US$ Bn)
FIG. 9 Global Cryoablation Market for Tumor Ablation, 2015 – 2025 (US$ Bn)
FIG. 10 Global Other technologies Market for Tumor Ablation, 2015 – 2025 (US$ Bn)
FIG. 11 Global Tumor Ablation Market for Surgical ablation, 2015 – 2025 (US$ Bn)
FIG. 12 Global Tumor Ablation Market for Laparoscopic ablation, 2015 – 2025 (US$ Bn)
FIG. 13 Global Tumor Ablation Market for Percutaneous ablation, 2015 – 2025 (US$ Bn)
FIG. 14 Global Tumor Ablation Market for Liver cancer, 2015 – 2025 (US$ Bn)
FIG. 15 Global Tumor Ablation Market for Lung Cancer, 2015 – 2025 (US$ Bn)
FIG. 16 Global Tumor Ablation Market for Kidney Cancer, 2015 – 2025 (US$ Bn)
FIG. 17 Global Tumor Ablation Market for Bone metastasis, 2015 – 2025 (US$ Bn)
FIG. 18 Global Tumor Ablation Market for Other Application, 2015 – 2025 (US$ Bn)
FIG. 19 Latin America Tumor Ablation Market, 2015 – 2025 (US$ Bn)
FIG. 20 Middle East and Africa Tumor Ablation Market, 2015 – 2025 (US$ Bn)
Based on technology, the global tumor ablation market is segmented as follows:
Tumor ablation is a minimally invasive surgical procedure used to treat solid cancers, special probes are used to burn or freeze tumor without performing conventional surgery. These treatments are also sometimes perform in patients waiting for a liver transplant. Factors such as rising prevalence of different forms of cancer, growing number of hospitals, surgical, and ablation centers, technological advancements in ablation devices and growing adoption of tumor ablation procedures are driving the growth of tumor ablation market globally. It is observed that in the base year 2016, radiofrequency ablation held largest market share and it is anticipated that it will grow at highest CAGR during forecast period due to factors such as less risk of tissue damage, widely accepted method for small tumors and faster recovery would influence the growth of radiofrequency ablation market globally. Radiofrequency ablation is commonly used to treat cancer in bone, kidney, liver, lung and prostate.
Based on treatment, the global tumor ablation market is segmented as follows:
Ablation refers to removal tissue from the body; tumor ablation is a minimally invasive surgical procedure used to treat solid cancers, special probes are used to burn or freeze tumor without the usual surgery. Factors such as increasing prevalence of different forms of cancer, rising demand for minimally invasive procedures, technological advancements in the field of ablation and rising number of hospitals, surgical and ablation centers are driving the growth of tumor ablation market globally. It is observed that in the base year 2016, surgical ablation held the largest market share due to factors such as rising prevalence of liver and breast cancer and increasing use of thoracoscopic surgical ablation are fueling the growth of surgical ablation market worldwide. There are different types of ablations and various techniques are used to perform the removal of tissue, depending on the nature of the issue. Surgical ablation may be performed with a laser or radio frequency emissions may be used.
Based on application, the global tumor ablation market is segmented as follows:
Tumor ablation is a minimally invasive procedure that is commonly used in the treatment of tumors of liver, kidney, bone, and lung. Special probes are used to burn or freeze tumor without the usual surgery; these treatments are also sometimes performed in patients waiting for liver transplant. Factors such as rising prevalence of different forms of cancer, technological advancements in ablation devices and growing adoption of tumor ablation procedures are driving the growth of tumor ablation market globally. It is observed that, in the base year 2016, liver cancer is largest revenue generating segment because of increase in prevalence of liver cancer and tumor ablation is globally accepted procedure in treatment of solid tumors in liver for patient where surgical procedure is not possible or preferred. Tumor ablation are also sometimes performed in patients waiting for a liver transplant. Radiofrequency ablation is used primarily to shrink or slow down the growth of liver carcinoma; it is usually done as an outpatient procedure under light sedation.
For the purpose of this study, the global tumor ablation market is categorized into:
In the base year 2016, North America dominated the tumor ablation market in terms of revenue and it is anticipated that it will show significant growth during forecast period. The U.S. was observed as the largest country-level market in North America. Factors such as increasing prevalence of different forms of cancer, advanced healthcare infrastructure, higher cost of therapy, technological advances and upsurge funding by the government are the prime contributors to the dominance of North America. It is anticipated that Asia Pacific will grow at the highest CAGR during the forecast period due to developing economic condition, improved treatment access, improvement in awareness among general patient population, rising medical expenditures in emerging economies such as India, China and Japan, growing market penetration of major players in this region would drive the market growth in Asia Pacific during forecast period 2017-2025.
